Cullinan Oncology
cullinanoncology.comLocations
Cambridge, MA, USA
industry
Biotechnology · DeepTech · Finance · Health
Size
51-200 employees
Stage
Series A
founded in
2017
Cullinan Oncology is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's therapeutics are developed via assets sourced internally through dry lab or externally through business, academic and pharma collaborations, enabling researchers to get a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model.
Something looks off?Open jobs at Cullinan Oncology